Recombinant human laminin-5 domains. Effects of heterotrimerization, proteolytic processing, and N-glycosylation on alpha3beta1 integrin binding.
about
Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma1 and gamma2 chainsLaminin 332 processing impacts cellular behaviorCrystal Structure of the LG1-3 Region of the Laminin 2 ChainRegulation of biological activity and matrix assembly of laminin-5 by COOH-terminal, LG4-5 domain of alpha3 chain.Epitope mapping of function-blocking monoclonal antibody CM6 suggests a "weak" integrin binding site on the laminin-332 LG2 domainWhy integrin as a primary target for imaging and therapy.Novel ENAM and LAMB3 mutations in Chinese families with hypoplastic amelogenesis imperfectaIntegrin α3β1 as a breast cancer targetN-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.The EMILIN/Multimerin family.Components of cell-matrix linkage as potential new markers for prostate cancer.Molecular dissection of the alpha-dystroglycan- and integrin-binding sites within the globular domain of human laminin-10.The requirement of the glutamic acid residue at the third position from the carboxyl termini of the laminin gamma chains in integrin binding by laminins.Laminin deposition in the extracellular matrix: a complex picture emerges.The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins.Prostate specific membrane antigen produces pro-angiogenic laminin peptides downstream of matrix metalloprotease-2.Expression and chain assembly of human laminin-332 in an insect cell-free translation system.
P2860
Q24652418-FB1934B2-B683-46C9-AD48-A232625388A8Q27021764-06BD08AA-C572-42E9-AB00-A3F7E99DD249Q27646293-A539EB38-CF36-4275-9D10-B6F0EA6364E1Q31146677-E5FFAEE3-00FE-4B56-BF1E-F6F280EC80E5Q33868001-2C966515-0BA8-4F2D-81CD-CC2E41AA04F7Q34912582-18BB88CB-2E49-4210-815F-50E494430D90Q35175229-2C676F12-B72D-43F9-B176-195AA9CDE028Q35539262-3277E0BA-BCC7-4B67-A085-4857154EF4DDQ37142796-5F48EF47-BE07-4024-AFCF-382C9DA6F6C7Q38008348-DEC4B4AA-AD09-4311-BFB2-C3E9CAEA3AFDQ38161339-FF1479D5-3AA6-4488-ADAB-BED145D717A0Q38346410-86EBD75E-BCF9-431B-BF3A-6154388FDD1BQ40169866-1B442B2F-C614-48AC-9CF1-6B2A8200CF3DQ42693930-D850A093-B715-452D-B002-AFE508501806Q43159925-24DE1F6D-FAB1-475D-BAC1-D540C825CD03Q50899715-5B247278-8406-4971-BCA8-7AC6E476B5A0Q52692420-7E5FFEF5-6A09-4F17-8320-BDBDEFC19708
P2860
Recombinant human laminin-5 domains. Effects of heterotrimerization, proteolytic processing, and N-glycosylation on alpha3beta1 integrin binding.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Recombinant human laminin-5 do ...... alpha3beta1 integrin binding.
@en
type
label
Recombinant human laminin-5 do ...... alpha3beta1 integrin binding.
@en
prefLabel
Recombinant human laminin-5 do ...... alpha3beta1 integrin binding.
@en
P2093
P2860
P356
P1476
Recombinant human laminin-5 do ...... alpha3beta1 integrin binding.
@en
P2093
Alletta Schmidt-Hederich
Gottfried Pohlentz
Jasna Peter-Katalinic
Johannes A Eble
Kerstin Künneken
Neil Smyth
Peter Bruckner
Uwe Odenthal
P2860
P304
P356
10.1074/JBC.M310424200
P407
P577
2003-11-11T00:00:00Z